Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. De plus, nous expédions RALBP1 Protéines (14) et RALBP1 Kits (9) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 120 products:
Human Monoclonal RALBP1 Primary Antibody pour IP, ELISA - ABIN564745
Smith, Oxford, Baras, Owens, Havaleshko, Brautigan, Safo, Theodorescu: Expression of ral GTPases, their effectors, and activators in human bladder cancer. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Show all 6 Pubmed References
Human Polyclonal RALBP1 Primary Antibody pour FACS, IF (p) - ABIN1387311
Deutsch, Graffeo, Rokosh, Pansari, Ochi, Levie, Van Heerden, Tippens, Greco, Barilla, Tomkötter, Zambirinis, Avanzi, Gulati, Pachter, Torres-Hernandez, Eisenthal, Daley, Miller: Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. dans Cell death & disease 2015
Human Monoclonal RALBP1 Primary Antibody pour ELISA - ABIN564744
Fillatre, Delacour, Van Hove, Bagarre, Houssin, Soulika, Veitia, Moreau: Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: the role of targeting signals and of protein-protein interactions. dans FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012
Human Polyclonal RALBP1 Primary Antibody pour ELISA, WB - ABIN564743
Wu, Owens, Chandra, Popovic, Conaway, Theodorescu: RalBP1 is necessary for metastasis of human cancer cell lines. dans Neoplasia (New York, N.Y.) 2010
Affects dynamics of the actin cytoskeleton, signalling from Ral (Montrer rala Anticorps) to RLIP is required for gastrulation.
These results demonstrate that to participate in the control of the actin cytoskeleton, RLIP needs its complete N-terminal region coding for the mu2BD and the GAP domain.
The results show that ARNO (Montrer CYTH2 Anticorps) interaction with the RLIP76 N-terminus regulates cell spreading and motility via PI3K and Arf6 (Montrer ARF6 Anticorps), independent of RLIP76 control of Rac (Montrer AKT1 Anticorps).
RLIP76 acts as a scaffold at recycling endosomes by binding activated R-Ras, recruiting ARNO (Montrer CYTH2 Anticorps) to activate Arf6 (Montrer ARF6 Anticorps), thereby contributing to cell spreading and migration.
a fundamental role of RLIP76 in regulating the function of obesity-promoting pro-inflammatory cytokines
RalBP1 is a gene regulating the seizure threshold and synaptic inhibition in mice
results establish that RLIP76 is required for efficient endothelial cell function and angiogenesis in solid tumors
RLIP76 represents a mechanistically significant target for developing effective interventions in aggressive and refractory pancreatic cancers
Studies confirmed a model in which RLIP76 plays a central role in the pathogenesis of metabolic syndrome and RLIP76 loss causes profound and global alterations of MSy signaling functions.
Findings show a fundamental role of RLIP76 in chemical carcinogenesis.
Because RLIP76 is induced by oxidative stress, it could play a role in insulin (Montrer INS Anticorps) resistance seen in pathological conditions characterized by increased oxidative stress
Data show that RLIP76 knockout mice are extremely sensitive to irradiation.
In the exons and exon-intron boundaries of ABCB5 (Montrer ABCB5 Anticorps) and RLIP76 genes.
the miR143-3p level was markedly lower in participants with ovarian cancer compared with normal control, while the expression of RALBP1 mRNA and protein were evidently overexpressed in participants with ovarian cancer compared with normal control.
RLIP76 knockdown increased autophagic flux and apoptosis in U251 glioma cells.
Phosphorylation level of Akt (Montrer AKT1 Anticorps) declined from 138.45+/-13.8 to 69.9+/-29.7% in SGC (Montrer SGCB Anticorps)-7901, and from 115.5+/-26.6 to 49.07+/-27% in MGC-803 and phosphorylation level of mTOR (Montrer FRAP1 Anticorps) also significantly decreased.While apoptosis of gastric cancer(GA) cells increased which we verified with apoptosis proteins and staining analysis. Our data showed that RLIP76 plays a significant oncogenic role in GC and it maybe a potential target in GC
Anti-tumor effect was exerted when miR (Montrer MLXIP Anticorps)-124 directly targeted RLIP76, a stress-inducible transporter that plays a crucial role in the development of melanoma.
report showed that RLIP76 expression was significantly increased in breast cancer samples and positively correlated with the malignant status of breast cancer patients; results indicated that high RLIP76 expression was associated with poor prognosis of breast cancer patients
RLIP76 expression is induced by TNF-alpha (Montrer TNF Anticorps) and follows the induction kinetics of inflammation markers, suggesting that inflammation can influence RLIP76 expression at the blood brain barrier.
RLIP76 downregulation in HT29 CRC (Montrer CALR Anticorps) cells suppressed cell growth, enhanced cell apoptosis, induced cell cycle arrest, and inhibited cell invasion by decreasing MMP2 (Montrer MMP2 Anticorps) expression.
High RLIP76 expression is associated with a poor outcome of meningioma.
results revealed that the effect of miR (Montrer MLXIP Anticorps)-101 on prostate cancer cell apoptosis was due to RLIP76 regulation of the PI3K (Montrer PIK3CA Anticorps)/Akt (Montrer AKT1 Anticorps)/Bcl-2 (Montrer BCL2 Anticorps) signaling pathway
Can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. Mediates ATP-dependent transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX) and is the major ATP-dependent transporter of glutathione conjugates of electrophiles (GS-E) and DOX in erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. Serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with CDK1 to switch off endocytosis, One of its substrates would be EPN1/Epsin (By similarity).
ralA binding protein 1
, Ral interacting protein
, ralA-binding protein 1
, ralA-binding protein 1-like
, DNP-SG ATPase
, Ral-interacting protein 1
, dinitrophenyl S-glutathione ATPase
, ral-interacting protein 1
, 76 kDa Ral-interacting protein